Skip to main content

Winton Group Ltd

SEC CIK
0001612063
Latest filing
Aug 7, 2026

HZNP holding history

Horizon Therapeutics Public Ltd Co in every 13F filed by Winton Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HZNP overviewAll 13F holders of HZNPFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
9
Since Q1 2021
Holdings of HZNP by Winton Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−2,617−100.0%Sold outHolders
Q3 20232,617$302.8K<0.1%−12−0.5%ReducedHolders
Q2 20232,629$270.4K<0.1%−8,275−75.9%ReducedHolders
Q1 202310,904$1.19M0.1%−621−5.4%ReducedHolders
Q4 202211,525$1.31M0.1%−2,080−15.3%ReducedHolders
Q3 202213,605$842.0K0.1%+3,548+35.3%AddedHolders
Q2 202210,057$802.0K<0.1%+10,057NewHolders
Q1 20220$00.0%−3,304−100.0%Sold outHolders
Q4 20213,304$356.0K<0.1%+1,179+55.5%AddedHolders
Q3 20212,125$233.0K<0.1%+2,125NewHolders
Q2 20210$00.0%−3,213−100.0%Sold outHolders
Q1 20213,213$296.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.